换一批
换一批Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes.
作者：
Aliki,Xochelli [1]
;
Panagiotis,Baliakas [2]
;
Ioannis,Kavakiotis [2]
;
Andreas,Agathangelidis [3]
;
Lesley-Ann,Sutton [1]
;
Eva,Minga [4]
;
Stavroula,Ntoufa [2]
;
Eugen,Tausch [5]
;
Xiao-Jie,Yan [1]
;
Tait,Shanafelt [1]
;
Karla,Plevova [6]
;
Myriam,Boudjogra [7]
;
Davide,Rossi [8]
;
Zadie,Davis [9]
;
Alba,Navarro [10]
;
Yorick,Sandberg [11]
;
Fie Juhl,Vojdeman [12]
;
Lydia,Scarfo [13]
;
Niki,Stavroyianni [14]
;
Andrey,Sudarikov [15]
;
Silvio,Veronese [4]
;
Tatiana,Tzenou [16]
;
Teodora,Karan-Djurasevic [17]
;
Mark,Catherwood [18]
;
Dirk,Kienle [19]
;
Maria,Chatzouli [20]
;
Monica,Facco [21]
;
Jasmin,Bahlo [6]
;
Christiane,Pott [22]
;
Lone Bredo,Pedersen [23]
;
Larry,Mansouri [24]
;
Karin E,Smedby [25]
;
Charles C,Chu [15]
;
Véronique,Giudicelli [2]
;
Marie-Paule,Lefranc [5]
;
Panagiotis,Panagiotidis [26]
;
Gunnar,Juliusson [7]
;
Achilles,Anagnostopoulos [27]
;
Ioannis,Vlahavas [27]
;
Darko,Antic [19]
;
Livio,Trentin [28]
;
Marco,Montillo [16]
;
Carsten,Niemann [3]
;
Hartmut,Döhner [29]
;
Anton W,Langerak [30]
;
Sarka,Pospisilova [23]
;
Michael,Hallek [18]
;
Elias,Campo [15]
;
Nicholas,Chiorazzi [6]
;
Nikos,Maglaveras [14]
;
David,Oscier [9]
;
Gianluca,Gaidano [24]
;
Diane F,Jelinek [13]
;
Stephan,Stilgenbauer [7]
;
Ioanna,Chouvarda [31]
;
Nikos,Darzentas [12]
;
Chrysoula,Belessi [11]
;
Frederic,Davi [32]
;
Anastasia,Hadzidimitriou [6]
;
Richard,Rosenquist [31]
;
Paolo,Ghia [9]
;
Kostas,Stamatopoulos [22]
作者单位：
Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
[1]
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
[2]
Department of informatics, Aristotle University of Thessaloniki, Thessaloniki, Greece.
[3]
Division of Experimental Oncology and Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy.
[4]
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
[5]
Department of Internal Medicine III, Ulm University, Ulm, Germany.
[6]
Feinstein Institute for Medical Research, Northwell Health, Manhasset, New York.
[7]
Department of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
[8]
Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
[9]
Department of Hematology, Hopital Pitie-Salpetriere and University Pierre et Marie Curie, Paris, France.
[10]
Division of Haematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
[11]
Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom.
[12]
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Barcelona, Spain.
[13]
Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
[14]
Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
[15]
Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece.
[16]
National Research Center for Hematology, Moscow, Russia.
[17]
Molecular Pathology Unit and Haematology Department, Niguarda Cancer Center, Niguarda Ca' Granda Hospital, Milan, Italy.
[18]
First Department of Propaedeutic Medicine, University of Athens, Athens, Greece.
[19]
Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
[20]
Department of Haemato-Oncology, Belfast City Hospital, Belfast, United Kingdom.
[21]
Hematology Department, Nikea General Hospital, Piraeus, Greece.
[22]
Department of Medicine, Hematology and Clinical Immunology Branch, Padua University School of Medicine, Padova, Italy.
[23]
Department I of Internal Medicine and Center of Integrated Oncology, University Hospital Cologne, Cologne, Germany.
[24]
Second Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
[25]
Department of Medicine Solna, Clinical Epidemiology Unit, Karolinska Institutet, Stockholm, Sweden.
[26]
IMGT®, the international ImMunoGeneTics information system®, Université de Montpellier, LIGM, Institut de Génétique Humaine IGH, UPR CNRS 1142, Montpellier, France.
[27]
Lund University and Hospital Department of Hematology, Lund Stem Cell Center, Lund, Sweden.
[28]
Clinic for Hematology, Clinical Center, Belgrade, Serbia.
[29]
Medical faculty, University of Belgrade, Belgrade, Serbia.
[30]
Laboratory of Medical Informatics, Aristotle University of Thessaloniki, Thessaloniki, Greece.
[31]
Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States.
[32]
Institute of Applied Biosciences, CERTH, Thessaloniki, Greece. anastasiaxtz@gmail.com.
[33]
Università Vita-Salute San Raffaele and IRCCS Istituto Scientifico San Raffaele, Milan, Italy.
[34]
主题词
氨基酸序列(Amino Acid Sequence);女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);免疫遗传学(Immunogenetics);免疫球蛋白重链(Immunoglobulin Heavy Chains);免疫球蛋白可变区(Immunoglobulin Variable Region);白血病, 淋巴细胞, 慢性, B细胞(Leukemia, Lymphocytic, Chronic, B-Cell);男(雄)性(Male);体细胞高突变, 免疫球蛋白(Somatic Hypermutation, Immunoglobulin)
DOI
10.1158/1078-0432.CCR-16-3100
PMID
28536306
发布时间
2018-06-20
- 浏览21
Clinical cancer research
Clinical cancer research
5292-5301页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
